Fractionated Radiotherapy With Stereotactic Radiosurgery Boost Controls Gross Disease in Grade 2 Meningioma
We found 100% in-field local control at 3 years from an SRS boost to fractionated RT targeting gross disease with an acceptable toxicity profile, suggesting this may be an effective and improved adjuvant treatment strategy in patients with grade 2 meningioma.
Authors
- Rebecca Calafiore (ORCID: https://orcid.org/0000-0003-1567-1942)
- Benjamin S. Ramsey (ORCID: https://orcid.org/0000-0002-0337-7976)
- Corbin A. Helis (ORCID: https://orcid.org/0000-0001-6097-7882)
- Paul Marcet
- James D. Ververs (ORCID: https://orcid.org/0000-0002-6308-1317)
- Carol Kittel (ORCID: https://orcid.org/0000-0002-4512-0634)
- Adrian W. Laxton (ORCID: https://orcid.org/0000-0002-4631-5476)
- Michael D. Chan (ORCID: https://orcid.org/0000-0002-5278-6709)
- Christina K. Cramer (ORCID: https://orcid.org/0000-0001-7618-3921)
- Stephen B. Tatter (ORCID: https://orcid.org/0000-0002-1063-0431)
- Heather D. Pacholke
- Marc Benayoun (ORCID: https://orcid.org/0000-0002-0337-517X)
- Eleanor Smith (ORCID: https://orcid.org/0000-0001-8502-8974)
- Jaclyn J. White
Institutions
- Alexander T. Augusta Military Medical Center (US)
- Neurological Surgery (US)
- Wake Forest University (US)
Publication Details
- Journal
- World Neurosurgery
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1016/j.wneu.2024.11.012
- Citations
- 1
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 0.39